Literature DB >> 18949271

Biochemical evaluation of focal non-reperfusion cerebral ischemia by middle cerebral artery occlusion in rats.

Benedicto Oscar Colli1, Daniela Pretti da Cunha Tirapelli, Carlos Gilberto Carlotti, Luiza da Silva Lopes, Luis Fernando Tirapelli.   

Abstract

Cerebral ischemia is an important event in clinical and surgical neurological practice since it is one of the diseases that most compromise the human species. In the present study 40 adult rats were submitted to periods of focal ischemia of 30, 60 and 90 min without reperfusion and animals submitted to a sham procedure were used as controls. We analyzed the levels of ATP, malondialdehyde and caspase-3. No significant differences in the biochemical measurements were observed between the right and left brain hemispheres of the same animal in each experimental group. Reduced ATP levels were observed after the three periods of ischemia compared to the sham group. No significant increase in malondialdehyde or caspase-3 levels was observed. Despite significant changes in ATP levels, the results indicated cell viability in the ischemic region as shown by the low rates of lipid peroxidation and apoptosis, findings probably related to the lack of reperfusion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18949271     DOI: 10.1590/s0004-282x2008000500023

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

1.  Ulinastatin attenuates cerebral ischemia-reperfusion injury in rats.

Authors:  Hai-Ming Chen; Huan-Sen Huang; Lin Ruan; Yan-Bing He; Xiong-Juan Li
Journal:  Int J Clin Exp Med       Date:  2014-05-15

2.  Remifentanil preconditioning alleviating brain damage of cerebral ischemia reperfusion rats by regulating the JNK signal pathway and TNF-α/TNFR1 signal pathway.

Authors:  Yan Zhang; Yan-Wei Li; Ya-Xin Wang; Hong-Tao Zhang; Xiao-Mei Zhang; Yu Liang; Xiu-Shan Zhang; Wen-Sheng Wang; Hai-Gen Liu; Yi Zhang; Ling Zhang; Yu-Hua Zheng
Journal:  Mol Biol Rep       Date:  2013-11-05       Impact factor: 2.316

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.